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ABSTRACT
A cap-containing oligonucleotide has been isolated from a
T ribonuclease hydrolysate of total Simian Virus 40-specific
late RNA and its structure has been determined as 7mG(5')ppp(5')
mAmpU(m)pUp(Up,Cp)ApGp. This oligonucleotide constitutes the
major 5' terminus of both late mRNA species, 16S and 19S. As-
suming that viral mRNA "caps" are derived from a 5'-terminal
triphosphate or diphosphate, these results mean that late tran-
scription is (mainly) initiated at nucleotide L 308 (numbering
system of Simian Virus 40 DNA, cf. Fiers et al. (1978) Nature,
273, 113-120). The cap is followed by a contiguous leader
sequence which is at least 194 nucleotides long.
INTRODUCTION
Simian Virus 40 (SV40) RNA is capped (1), and the cap struc-
tures of the viral late mRNAs have been characterized in detail
(2,3). At least 70 % of the SV40 late, cytoplasmic mRNAs start
with either 7-methyl-guanosine-5'-triphosphoryl-5'-6,2'-dimethyl-
adenylyl-uridylic acid or 7-methyl-guanosine-5'-triphosphoryl-
5'-6,2'-dimethyladenylyl-2'-methyl uridylyl-uridylic acid, the
latter being relatively enhanced in the 16S mRNA species (2).
Furthermore, the SV40 late mRNAs are spliced, consisting of a
5'-terminal untranslated leader segment of about 150-200 nucleo-
tides joined covalently to the coding portion of the RNAs (4-9).
In the case of 16S RNA, the approximate localization of the lead-
er sequence on the genome has been established by direct struc-
tural analysis (8,9), but no information was obtained as to
which site on the genome actually corresponded to the capped
5' end of the leader sequence, nor had a capped T1 oligonucleo-
tide been detected in the ribonuclease T1 fingerprints of the
X) Information Retrieval Limited 1 Falconberg Court London Wl V 5FG England 2359
Nucleic Acids Research
entire 16S RNA molecule or the isolated leader segment.
In the present study we report the isolation of a cap-con-
taining oligonucleotide from T1 digests of SV40-specific, cyto-
plasmic late mRNA. This information plus supplementary data on
T1 oligonucleotides present in the mRNA digest in correlation
with the primary nucleotide sequence of the SV40 genome allowed
us to localize the 5' terminus of the untranslated leader se-
quence at nucleotide L 308 (numbering system as in ref. 10).
MATERIALS AND METHODS
Highly P-labeled SV40 late mRNA was isolated from SV40-
infected CV-1 monkey cells and purified from the cytoplasmic
extract by oligo(dT)-cellulose selection and hybridization to
SV40 DNA-Sepharose as described previously (2). The viral RNA
was dissolved in a small volume (10 X) of 0.02 M Tris-Cl, 2 mM
EDTA, pH 7.4, and hydrolysed for 30 min at 37°C with T ribonu-
clease (Sankyo Co. Ltd). Subsequently the reaction mixture was
diluted with an excess (e.g., 200 X) of 0.6 M KCl, 0.05 M mor-
pholine-HCl buffer, pH 8.5, and loaded directly onto an oligo
(dT)-cellulose column which had been equilibrated with the same
buffer. This step eliminated the poly(A)-containing material
which could interfere with the ensuing isolation procedure. The
effluent of the column, containing the non-bound oligonucleo-
tide material, was collected and diluted with ethanol to a final
concentration of 20 %. In this way the resulting composition
corresponded to the composition of the starting solution used
for isolation of sugar derivatives containing a 2',3' cisdiol
group by chromatography on acetylated dihydroxyboryl (DBAE)-
cellulose (11,12). The oligonucleotide material was loaded onto
a pre-equilibrated column (0.7 x 0.2 cm) of acetylated DBAE-
cellulose (Collaborative Research, Inc.) at 4°C and the column
was washed with approximately 10 column-volumes of starting buf-
fer (i.e., 0.6 M KCl, 0.05 M morpholine-HCl buffer, pH 8.5, 20 %
ethanol). A T1 hydrolysate of 400 Pg of carrier yeast ribosomal
RNA diluted with 0.5 ml starting buffer was then loaded onto the
DBAE-cellulose column and the column was washed again with an-
other 10 column-volumes of starting solution. The material still
bound was then eluted with starting buffer containing also
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0.1 M sorbitol, and finally the column was stripped with 0.2 M
NaCl, 0.05 M sodium acetate buffer, pH 5.0. The peak fractions
of each elution step were collected, diluted with water to a
final salt concentration of 0.02 M and desalted on a column (0.7
x 1.0 cm) of DEAE-cellulose (Whatman DE-52). The oligonucleotide
material retained was recovered by elution with I - 1.5 ml of
I M triethylammonium carbonate, pH 10, and the eluate was evapo-
rated to dryness. The residue was redissolved in a few X of
water and fractionated two-dimensionally by homochromatography
on PEI (polyethyleneimine)-cellulose plates (Machery-Nagel &
Co.) (13).
Specific products were recovered from the thin-layer plate
by a micro-elution technique (13) and further analyzed by di-
gestion with pancreatic ribonuclease A (14). Ribonuclease-A-re-
sistant products were reeluted and further degraded with Peni-
cillium nuclease P1 (2).
RESULTS
A typical elution profile of the DBAE-cellulose column is
shown in Fig. 1. Fingerprint analysis revealed that the huge
peak of non-bound material contains all the products present in
a typical T1 map of total SV40 late mRNA. Ap-rich oligonucleo-
tides, however, are preferentially retained by the cellulose and
therefore appear in submolar quantity (data not shown). The irre-
gular pattern of the material eluted by the T1 hydrolysate of
carrier yeast RNA represents material that attaches rather non-
specifically to the column resin. The next peak, eluted by the
sorbitol solution, contained the capped oligonucleotide(s) - as
will be demonstrated below - in addition to a relatively high
background of material of random origin. The final wash again
consisted of non-specifically bound oligonucleotides but did not
contain any capped product, as checked by further analysis of
the eluate with P1 nuclease and bacterial alkaline phosphatase
as described previously (2).
The peak eluted with the sorbitol-containing buffer was
collected, desalted, and fingerprinted as described in Materials
and Methods. An autoradiograph of the two-dimensional fractiona-
tion is shown in Fig. 2 together with a regular fingerprint of
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Figure I Elution profile of the DBAE-cellulose chromatography.
(32P)-labeled, SV40-specific, cytoplasmic mRNA was digested
with ribonuclease T1, and after dilution with "starting buffer"
(0.6 M KCI, 0.05 M morpholine-HCl buffer, pH 8.5, 20 % ethanol),
loaded onto a DBAE-cellulose column. The first peak to the left
corresponds to non-bound material that runs through the column
(the radioactivity corresponds to the left ordinate). The more
expanded scale at the right applies to the remainder of the elu-
tion pattern. The successive elutions are indicated by arrows
(a) T1 hydrolysate of carrier yeast RNA diluted with starting
buffer. (b) "starting solution" containing in addition 0.1 M sor-
bitol, and (c) 0.2 M NaCl, 0.05 M sodium acetate (pH 5).
total SV40 late mRNA. As the 19S mRNA is only a minor species,
all the major spots present in the latter fingerprint are de-
rived from the 16S mRNA (8). Although the normal, 16S mRNA type
T1 pattern is recognizable in the sorbitol peak from the DBAE-
cellulose chromatography, a discrete set of new products can
readily be seen. All the spots were further characterized by
double digestion with pancreatic ribonuclease and at least 6
contained the previously characterized 5' cap structure (vide
infra, Fig. 4). No structural difference between these spots was
evident from the ribonuclease-A analysis. Hence, the resolution
between this variety of spots (at least 6 were resolved) is pre-
sumably due to the procedures used and does not necessarily in-
dicate different oligonucleotides. A similar occurrence of dou-
bled spots in the first (i.e., the electrophoretic) dimension
has recently also been described for the capped 5' terminus of
adenovirus-2 late mRNAs isolated by chromatography on DBAE-cel-
lulose (12,15). The authors suggested that the spot doubling
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Figure 2 : Two-dimensional fractionation on PEI-cellulose thin-
layer plates (20 x 20 cm) according to the procedure of
Volckaert et al. (13) of : (a) a T1 hydrolysate of cytoplasmic
SV40 late mRNA. The analysis of such a fingerprint has been
described in a previous publication (8). As the 19S RNA repre-
sents at most 20 % of the viral late RNA, the 19S-specific
oligonucleotides are hardly visible; and (b) material derived
from a similar TI hydrolysate as in (a), but which was retained
on a DBAE-cellulose column and was eluted with the sorbitol-con-
taining buffer. Spots indicated by an arrow were shown upon en-
zymic analysis to contain the cap structure (5 of them were rath-
er well-defined spots, while the 6th had a streaked appearance).
might perhaps be caused by a different degree of methylation at
the N position of the adenosine residue of the cap. However,
this explanation is not applicable to our observations because
only the 6,2'-doubly-methylated adenosine was found to be part
of the SV40 cap structure in our preparations (2). Moreover,
singly- or doubly-methylated adenosine residues are not expected
to give any resolution in the corresponding cap structures upon
electrophoretic fractionation at pH 3.5 (3,16-18). Also, the ap-
parent heterogeneity in the second (i.e., chromatographic) di-
mension is primarily not due to a difference in composition, as
shown by analysis with nucleases, but is largely caused by an
artifact which arises in the separation of polyphosphate groups
by homochromatography on PEI cellulose. Indeed, nuclease P -
generated cap structures of cellular mRNA were separated two-
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dimensionally on PEI cellulose: the first fractionation was by
electrophoresis on cellulose acetate and the separated components
were transferred to the PEI plate by reversed blotting; the sec-
ond dimension was developed either by ion-exchange chromatography
(2) or by displacement chromatography with homomixture 0 (13).
However, although the first dimension was identically clean in
both cases, displacement chromatography with the homomixture re-
sulted in a streaked appearance whereas the pattern obtained by
ion-exchange chromatography remained clean (our unpublished re-
sults). Nevertheless, the larger and more complex cap-containing
T1 oligonucleotide derived from SV40 RNA could only be resolved
satisfactorily by the system illustrated in Fig. 2. Ring opening
of the 7-methyl G and 2'-O methylation of the second residue can
explain only part of the diversity observed; alternate spatial
configuration in the polyphosphate-containing compounds (19) may
also be involved.
Fig. 3 shows the pancreatic ribonuclease analysis of one of
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0 ~ QApUp
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I~~~~~~~~~~
20~~~~~~
~~~10c
Figure 3 : Two-dimensional separation of a pancreatic ribonucle-
ase-A digest of T1 oligonucleotides on PEI-cellulose mini-plates
(6 x 10 cm) (14). (a) One of the new products present in the
fingerprint after specific enrichment (Fig. 2, panel b; all spots
indicated by an arrow gave the same double-digestion pattern).
The arrows indicate the four products obtained: Cp, Up, ApGp and
material remaining at the origin (cf. Fig. 4). (b) Diagram to
identify the double-digestion products. B denotes the position
of the blue dye and 0 marks the origin. (c) Ribonuclease-A anal-
ysis of the oligonucleotide with composition (Up,2Cp,Ap)Gp
(n° 121) which was recovered from a normal T1 fingerprint of
SV40 late mRNA.
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Figure 4 : Nuclease P analysis of the material recovered from
the origin of figure 3a. The material was eluted, digested with
nuclease P1 and the digest was fractionated two-dimensionally
on PEI-cellulose miniplates (6 x 10 cm) (2). The diagram shows
the position and identity of the different spots, as documented
in a previous paper (2). A-cap refers to the P1-generated
structure Gppp mAm; T2-cap marks the spot which probably
originates from incomplete cigestion and may contain undegraded
cap I ( Gppp mAmpU) and/or partially degraded cap II structure
( Gppp AmpUm). B indicates the position of the blue dye
marker and 0 corresponds to the origin.
the main new spots which appeared specifically on the map of the
sorbitol peak. No significant differences could be seen between
the miniplates of the several new spots (as described above).
The enzymic hydrolysis products were Cp, Up and ApGp in addition
to ribonuclease-A-resistant material which remained at the origin
because of its high charge. The degradation products were iden-
tified by their position, and their identity was confirmed by
alkaline hydrolysis (data not shown). The undegraded material at
the origin was eluted and further analyzed by digestion with P1
nuclease which released the following products: pU and to a les-
ser extent 2'-0-methyl-uridine-5'-phosphate (pUm); inorganic
phosphate (Pi), derived from the 3'-terminal nucleotide; and
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other undegraded products which in the system typically moved
as cap structures (Fig. 4). These analyses point to an oligonu-
cleotide which contains a mixed population of cap structures I
and II, identified previously (2), and furthermore the double-
digestion products Cp, Up and ApGp. We conclude from these anal-
yses that the cap-containing T1 oligonucleotide has the struc-
ture G(5')ppp(5') AmpUpUp(Up,Cp)ApGp and 7mG(5')ppp(5')mAmpUmp
Up(Up,Cp)ApGp. The reason for the multiple spots in the finger-
prints (Fig. 2) is not known for certain, but as different types
of further analyses all indicate an identical composition, the
diversity is presumably artifactual (cf. preceding paragraph).
The 5' start of the late SV40 mRNAs is believed to be lo-
cated in the Hind II + III restriction fragment C (4-6). An
inspection of the nucleotide sequence of this fragment (10,20,
21) reveals that the oligonucleotide UpUpApUpUpUpCpApGp (corres-
ponding to position 306-314 of the late region but presented
here as an RNA sequence; ref. 10) is the only T, product which
is ApGp terminal and which carries the specfic sequence ApUpUp
(derived from cap II; ref. 2) followed by pyrimidine nucleo-
tides (Fig. 5). This T oligonucleotide had previousiy Deen
shown not to be present as such in the leader sequence (8). Its
structure (containing ApUpUp) as well as its position in the
total sequence relative to the known part of the leader, had al-
ready previously led to the suggestion that it might correspond
to the 5' start of the SV40 late mRNAs (8). Indeed, we reported
that the unique and discriminative oligonucleotide CpCpUpCpCpGp
(code n° 140) was definitely present in the leader sequence.
Therefore, the 5' end must extend further counterclockwise from
nucleotide 343 (Fig. 5). The preceding oligonucleotides were
presumably also present, but they were not considered to be dis-
criminative, e.g., the T, products CpCpGp (no 020) and CpCpApGp
(no 021), although unique in the molecule, are relatively short
and may possibly be overestimated by slight contamination of the
viral late mRNA. The T, product CpGp (no 010) occurs twice: once
in the leader sequence and once more in the Hind II + III frag-
ment G of the coding region (10,22). The oligonucleotide with
composition (Up,2Cp,Ap)Gp (no 121) occurs three times in the 16S
mRNA, but each time it is present as a different sequence isomer.
Fortunately, these can easily be distinguished by analysis with
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U CA G G CC AUG G CU G C G CC G G CU G U CA C G
121 110 010 020 110 121
5 ., AA G G A G A A A G T C T C CAATAAAGT C CGG r A C C G A C G C G G C C G A C A G T G C
3. T T C C T C T T T C A G A G G T T A T T T C A G G CCATGGCT G C C G G C T G T C A C G
300 310 320 330
CCAGGCCUCCGUUAAGGUUCGUAGGUCAUGGACUGAAAGUAA..
021 140 202 210 101 211 111 003
G G T C C G G A G G C A A T T C C A A G C A T C C A G T A C C T G A C T T T C A T T
C C A G G C C T C C G T T A A G G T T C G T A G G T C A T G G A C T G A A A G T A A
340 350 360 370 380
Figure 5 : Nucleotide sequence of part of the Hind II + III
fragment C from the late region of SV40 DNA (10,20) and the
corresponding leader sequence of the viral late RNAs determined
by fingerprint analysis (8). The nucleotide numbers (below the
sequence) refer to the position of the fragment in the total
sequence of the SV40 DNA late region (10). The mRNA leader frag-
ment starts at position 308. The oligoribonucleotide numbers
(below the RNA sequence) are a code referring to the base com-
position of the corresponding T, products (33). All T, oligo-
nucleotides following the cap-containing TI oligonucleotide
have been identified in the fingerprint of the SV40 late mRNA.
ribonuclease A and/or U2. Digestion with ribonuclease A (Fig. 3c)
clearly shows the products ApCp and ApUp (both of which are spe-
cific for the isomers present in the leader sequence) in equimo-
lar amount with the product ApGp derived from the isomer UpCpCpAp
Gp (n° 121) present in the Hind II + III fragment K (10,23).
Further confirmation of the structures is given by U2 analysis,
which releases CpCpAp, UpCpAp, and UpCpCpAp, respectively, from
the 5' ends of the three sequence isomers in addition to their
respective 3'-terminal products UpGp, CpGp and Gp. From these
data it is evident that both sequence isomers CpCpApUpGp and
UpCpApCpGp are present in the leader fragment, and hence that
the latter extends continuously from the region previously
characterized (nucleotide 501 to 344) to nucleotide 316 where
it links to the capped oligonucleotide 7mG(5')ppp(5')mAmpU(m)
pUpUpCpApGp. These results, obtained by detailed oligonucleo-
tide analysis, proved that the sequence of the leader of the
viral late RNAs in this region corresponds exactly to the DNA
sequence of the genome.
DISCUSSION
The major 5'-terminal, cap-containing T1 oligonucleotide
of SV40 late mRNA has been isolated by chromatography on DBAE-
cellulose followed by fingerprinting, and it was identified by
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subsequent analysis with a number of nucleases. The rather
unique structure of this oligonucleotide enabled us to localize
unambiguously the 5' end of the late mRNAs on the DNA sequence
at nucleotide L 308.
No capped oligonucleotide had so far been found upon anal-
ysis of all the main T, products present in the fingerprint of
16S mRNA, although the various T oligonucleotides derived from
the leader fragment were all present in molar amounts (8). From
the present study, however, we learned that the cap-containing
oligonucleotide appears on such fingerprints in a series of re-
lated spots, a diversity which presumably originates from arti-
facts (e.g., abnormal chromatographic mobility due to the poly-
phosphate segment). Each of these individual spots must have
been considerably submolar compared to the regular products. The
radioactivity counts were too low to accurately determine whether
the sum of the 5 to 6 cap-containing oligonucleotides represents
one molar equivalent. We had previously reported that the caps of
the viral late RNAs are present in 0.5 molar ratio only (2).
Moreover, after we realized that the presumably unique, cap-con-
taining TI oligonucleotide was dispersed over at least 5 to 6
spots, the site of these spots in a normal TI fingerprint of 16S
mRNA was rigorously reinvestigated, and evidence was obtained
that, indeed, the capped oligonucleotide could be recovered from
this particular area of the plate (data not shown).
The presence of the degradation products pU and pUm in
ribonuclease-A-resistant material released from the capped oli-
gonucleotide shows that a mixed population of cap structures I
and II occurs in this oligonucleotide, thus demonstrating that
both caps are derived from the same 5' end (i.e., the same se-
quence on the RNA gives rise to cap I and cap II and the latter
is only a more methylated form of the former). Furthermore,
these results also show that the multiple cap-spots present in
the T1 fingerprint are in the first instance not due to a dif-
ferent degree of methylation. Because the isolation of capped
5' termini from total SV40 late mRNA, which includes 19S, 16S
and possibly even an 18S species, has revealed only one major
capped oligonucleotide, it follows that the different late RNA
species possess the same 5' terminus. It has recently been es-
tablished that SV40 16S and 19S share a common 5'-terminal
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leader sequence (5,6), and, therefore, our findings of a single
prominent 5'-terminal cap for the common leader fragment is not
unexpected.
Having established that the cap T1-oligonucleotide has the
structure G(5')ppp(5')mAmpU(m)pUp(Up,Cp)ApGp, it follows from
the known SV40 DNA sequence that this oligonucleotide is derived
from nucleotide L 308 and the following nucleotides in clockwise
direction (Fig. 5). Our previous studies had indicated that the
leader sequence is initiated before nucleotide L 344 and extends
continuously up to at least nucleotide 501, around which posi-
tion the splicing event occurs (8). In view of these results, we
have carefully analyzed again the T1 fingerprint of the SV40
late mRNA, and we did find all the expected products in the re-
gion immediately following the capped T1 oligonucleotide (Fig.
5). Therefore we can conclude that unlike the adenovirus-2 late
mRNAs, which undergo multiple splicing events in the leader se-
quence (24,25), the leader of the SV40 mRNA is at least 194 nu-
cleotides long and the segment between the cap and the start of
the single splice corresponds to a continuous sequence of the
DNA genome.
The only enzymic mechanisms of cap-formation which have so
far been identified in eukaryotic cells involve modification of
5' triphosphate or diphosphate termini (26). There is no unam-
biguous evidence that the latter can be generated also from
processed 5' ends. Therefore, the possibility should be serious-
ly considered that caps correspond really to initiation points
of transcription (26,27). If so, we have identified the major
start of SV40 late RNA transcription.
In the case of prokaryotes, the initiation of transcription
takes place at a distance of 6 to 7 nucleotides from a segment
of 7 nucleotides which are rather well conserved in all promotors.
On this basis, it could be proposed that the region on the SV40
genome before nucleotide L 308 corresponds to an eukaryotic pro-
moter. This region would then be recognized by RNA polymerase
II, which is responsible for all SV40-directed transcription.
However, there are several reasons to believe that the situation
may be more complex. First, it is well known that the start of
late transcription depends on the initiation of DNA replication,
and therefore the late transcriptional initiation complex may
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be a peculiar structure (although continuous DNA replication is
not required for maintenance of late transcription; refs. 28-30).
Furthermore, many viable deletion mutants have been isolated
which have the mutation around t*he Hpa II site or in the region
0.68 to 0.74 (31,32). Some of these mutants must have lost infor-
mation from the leader sequence and some may even have lost the
putative transcriptional initiation point identified in the pre-
sent communication. If so, then the most likely explanation for
the viability of these deletion mutants is that late transcrip-
tion can initiate at alternative positions. It should be noted,
in fact, that the SV40 late ribonuclease T caps 7mG(5')ppp(5')2 ap, G5)p('
AmpU and 7 G(5')ppp(5')mAmpUmpU, represented about 70 % or more
of the entire T2-resistant material isolated, but the origin of
the remaining fraction is still unknown. In order to obtain in-
formation on these aspects, we are now characterizing in detail
some of the aforementioned deletion mutants, both at the level
of the DNA sequence and at the level of the induced late mRNA.
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